The spectrum of Nocardia lung disease in cystic fibrosis

Galit Livnat-Levanon (Haifa, Israel), Galit Livnat, Meir Mei-Zahav, Lea Bentur, Huda Mussaffi, Hannah Blau

Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Session: Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Session type: Poster Discussion
Number: 2059
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Galit Livnat-Levanon (Haifa, Israel), Galit Livnat, Meir Mei-Zahav, Lea Bentur, Huda Mussaffi, Hannah Blau. The spectrum of Nocardia lung disease in cystic fibrosis. Eur Respir J 2015; 46: Suppl. 59, 2059

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Microevolution of pseudomonas aeruginosa in cystic fibrosis lungs
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014

Temporal progression of fungal microbiota in patients with cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015


Cystic fibrosis
Source: Respipedia Article
Year: 2018

Cystic fibrosis: Achromobacter xylosoxidans colonized patients have more severe respiratory disease
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013

Adaptation of prevotella during acute infectious pulmonary exacerbation
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

Does the cystic fibrosis phlegm feed the pseudomonas?
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016

Host specificity of pseudomonas aeruginosa isolates from patients with cystic fibrosis and patients from different clinical backgrounds
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014


Temperate bacteriophages of pseudomonas aeruginosa as markers of bacterial adaptation in CF and non-CF bronchiectasis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014


The characteristics of the minimum inhibitory concentration of antibiotics on pulmonary infections in patients with cystic fibrosis
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015


Non-tuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis
Source: International Congress 2019 – State of the art session: Respiratory infections
Year: 2019


Fungi communities detected by metagenomic tools in sputum in patients with cystic fibrosis
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013


MRI detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014

Emerging pathogens in cystic fibrosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=66
Year: 2006

Cystic fibrosis fibrosis bronchiectasis
Source: Virtual Congress 2020 – Paediatric year in review
Year: 2020

How useful is the lung ultrasound in cystic fibrosis?
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016


Evolution of the infectious disease in cystic fibrosis (CF)
Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases
Year: 2008


Lung clearance index predicts pulmonary exacerbations in cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014

Persistence of candida dubliniensis in the lower airways of cystic fibrosis patients
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015